# FDA Testing Protocol
# Advanced Neural Interface System with Quantum Integration
# Classification: Class III Medical Device
# Regulatory Path: PMA (Premarket Approval)

class FDAClinicalTrialProtocol:
    """Comprehensive FDA testing protocol for neural interface system"""
    
    # Phase I: Initial Safety Study
    PHASE_1_PROTOCOL = {
        'duration': '6 months',
        'subjects': 50,
        'sites': 3,
        'cost_estimate': 2500000,  # $2.5M
        'primary_endpoints': [
            'Device implantation safety',
            'Acute tissue response',
            'Basic functionality verification',
            'Initial neural signal quality'
        ],
        'safety_monitoring': {
            'frequency': 'Weekly',
            'metrics': [
                'Local tissue response',
                'Neural signal stability',
                'Device temperature',
                'Quantum coherence levels',
                'Adverse events tracking'
            ],
            'imaging_requirements': [
                'Weekly MRI',
                'Daily CT scans first week',
                'Monthly CT thereafter'
            ]
        },
        'data_collection': {
            'neural_recordings': '24/7 continuous',
            'physiological_markers': 'Hourly',
            'quantum_metrics': 'Continuous',
            'subject_assessments': 'Daily'
        }
    }
    
    # Phase II: Expanded Safety and Initial Efficacy
    PHASE_2_PROTOCOL = {
        'duration': '12 months',
        'subjects': 200,
        'sites': 10,
        'cost_estimate': 7500000,  # $7.5M
        'primary_endpoints': [
            'Long-term safety profile',
            'Functional effectiveness',
            'Neural integration stability',
            'Quantum coherence maintenance'
        ],
        'efficacy_metrics': [
            'Signal bandwidth',
            'Latency measurements',
            'Consciousness integration',
            'Reality manipulation accuracy',
            'Cross-dimensional stability'
        ],
        'cohort_design': {
            'control_group': 50,
            'active_device': 150,
            'randomization': 'Double-blind'
        }
    }
    
    # Phase III: Pivotal Study
    PHASE_3_PROTOCOL = {
        'duration': '24 months',
        'subjects': 1000,
        'sites': 25,
        'cost_estimate': 15000000,  # $15M
        'primary_endpoints': [
            'Clinical effectiveness',
            'Long-term safety',
            'Quality of life impact',
            'Consciousness enhancement metrics'
        ],
        'subgroup_analyses': [
            'Age stratification',
            'Medical condition categories',
            'Prior neural implant history'
        ]
    }
    
    # Required Testing Infrastructure
    TESTING_INFRASTRUCTURE = {
        'facilities': {
            'surgical_suites': 'ISO Class 5',
            'monitoring_rooms': 'ISO Class 6',
            'quantum_measurement_lab': 'ISO Class 4',
            'data_center': 'TIER IV'
        },
        'equipment': {
            'neural_monitoring': 'Advanced EEG/MEG systems',
            'quantum_systems': 'IBM Quantum processors',
            'imaging_systems': ['3T MRI', 'High-res CT', 'PET'],
            'backup_systems': 'Redundant power and data'
        },
        'personnel': {
            'neurosurgeons': 10,
            'neurologists': 20,
            'quantum_physicists': 5,
            'biomedical_engineers': 15,
            'data_scientists': 10,
            'clinical_staff': 50
        }
    }
    
    # Safety Monitoring Plan
    SAFETY_MONITORING = {
        'adverse_events': {
            'definitions': [
                'Neural tissue response',
                'Device malfunction',
                'Quantum decoherence',
                'Psychological effects'
            ],
            'reporting_timeline': {
                'severe': '24 hours',
                'moderate': '72 hours',
                'mild': '7 days'
            },
            'review_board': {
                'meeting_frequency': 'Weekly',
                'composition': [
                    'Chief Medical Officer',
                    'Principal Investigator',
                    'Safety Monitor',
                    'Biostatistician',
                    'Patient Representative'
                ]
            }
        },
        'stopping_rules': {
            'safety_thresholds': {
                'adverse_event_rate': '> 5%',
                'severe_event_rate': '> 1%',
                'quantum_instability': '> 2%'
            },
            'efficacy_boundaries': {
                'signal_quality': '< 90%',
                'coherence_level': '< 95%',
                'integration_success': '< 85%'
            }
        }
    }
    
    # Data Management and Analysis
    DATA_MANAGEMENT = {
        'collection_systems': {
            'primary': 'Custom Neural Data Platform',
            'backup': 'Redundant Cloud Storage',
            'quantum_data': 'Quantum State Storage'
        },
        'analysis_pipeline': {
            'real_time': [
                'Signal quality metrics',
                'Safety parameters',
                'Quantum coherence'
            ],
            'daily': [
                'Performance trends',
                'Safety summaries',
                'Integration metrics'
            ],
            'monthly': [
                'Efficacy analyses',
                'Safety reviews',
                'Regulatory reports'
            ]
        },
        'quality_control': {
            'data_validation': 'Automated + Manual',
            'audit_frequency': 'Monthly',
            'error_checking': 'Continuous'
        }
    }
    
    # Regulatory Documentation
    REGULATORY_DOCS = {
        'required_submissions': [
            'IDE Application',
            'Progress Reports',
            'Safety Reports',
            'Annual Updates',
            'Final Study Report'
        ],
        'timeline': {
            'ide_submission': 'Month 0',
            'first_patient': 'Month 6',
            'interim_analysis': 'Month 18',
            'study_completion': 'Month 42',
            'pma_submission': 'Month 48'
        }
    }
    
    # Budget Breakdown
    BUDGET = {
        'phase_1': {
            'direct_costs': 1500000,
            'indirect_costs': 500000,
            'equipment': 300000,
            'personnel': 200000
        },
        'phase_2': {
            'direct_costs': 4500000,
            'indirect_costs': 1500000,
            'equipment': 1000000,
            'personnel': 500000
        },
        'phase_3': {
            'direct_costs': 9000000,
            'indirect_costs': 3000000,
            'equipment': 2000000,
            'personnel': 1000000
        },
        'total_estimated_cost': 25000000  # $25M total
    }
